Pancreatic Cancer Clinical Trials

ReadTheTrial indexes 2 studies for Pancreatic Cancer. The most common development stage is N/A (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Pancreatic Cancer.

Pipeline by Phase

PhaseTrialsDistribution
N/A 1
50%
Phase 2 1
50%

Trial Status Breakdown

Trials for Pancreatic Cancer

EXCEED - A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

NCT05663515 · RECRUITING · N/A

A Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to Patients With CD70-Expressing Cancers

NCT02830724 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Pancreatic Cancer?

There are 2 clinical trials listed for Pancreatic Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Pancreatic Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Pancreatic Cancer trials in?

Current Pancreatic Cancer trials are distributed across: N/A (1), Phase 2 (1).

Find More Trials